Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 71,181 - 71,200 results of 111,122 for search '(( 50 ((ng decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (a decrease)) ))', query time: 1.73s Refine Results
  1. 71181
    Table_2_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx

    Table_2_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
    Save to List
    Saved in:
  2. 71182
    Food restriction increase the expression of mTORC1 complex genes in the skeletal muscle of juvenile pacu (<i>Piaractus mesopotamicus</i>)

    Food restriction increase the expression of mTORC1 complex genes in the skeletal muscle of juvenile pacu (<i>Piaractus mesopotamicus</i>) by Tassiana Gutierrez de Paula (821372)

    Published 2017
    Save to List
    Saved in:
  3. 71183
    Table_3_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx

    Table_3_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
    Save to List
    Saved in:
  4. 71184
    Table_1_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx

    Table_1_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
    Save to List
    Saved in:
  5. 71185
    Table_4_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx

    Table_4_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
    Save to List
    Saved in:
  6. 71186
    Table_6_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx

    Table_6_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
    Save to List
    Saved in:
  7. 71187
    Image_2_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.TIF

    Image_2_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.TIF by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
    Save to List
    Saved in:
  8. 71188
    Image_1_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.TIFF

    Image_1_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.TIFF by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
    Save to List
    Saved in:
  9. 71189
    Table_7_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx

    Table_7_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
    Save to List
    Saved in:
  10. 71190
    DataSheet1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.docx

    DataSheet1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.docx by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  11. 71191
    Presentation2_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX

    Presentation2_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  12. 71192
    Presentation1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX

    Presentation1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  13. 71193
    DataSheet1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.docx

    DataSheet1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.docx by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  14. 71194
    DataSheet1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.docx

    DataSheet1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.docx by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  15. 71195
    Presentation2_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX

    Presentation2_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  16. 71196
    Presentation3_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX

    Presentation3_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  17. 71197
    Presentation1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX

    Presentation1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  18. 71198
    Presentation1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX

    Presentation1_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  19. 71199
    Presentation2_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX

    Presentation2_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:
  20. 71200
    Presentation3_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX

    Presentation3_Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier.PPTX by Yi-Ping Chen (530619)

    Published 2022
    “…A series of MSNs with various charges and two different sizes of 50 and 200 nm were synthesized, which showed a uniform mesoporous structure with various surface zeta potentials ranging from +42.3 to −51.6 mV. …”
    Save to List
    Saved in:

Search Tools: